evolving research

The Bedari Kindness Institute director discusses the institute’s mission and the issue of trust on campus.

How UCLA is leading a campuswide movement to shape a more compassionate and connected world.

Fission mechanisms have implications for cancer, cardiovascular disease, neurodegenerative disorders and more, UCLA research shows.

The findings reveal precise viral-host interactions that could be targeted with new antivirals or vaccines.

With the fall quarter beginning, the chancellor shared a message with the campus community about UCLA’s continuing commitment to educate, discover and serve.

In patient cells in culture, the gene therapy successfully restored normal alpha-globin protein production to healthy levels.

Advancement shows promise for technology to assist immobilized individuals.

Chancellor Julio Frenk shared a message with the campus community about elevating UCLA’s mission as the university addresses unprecedented challenges.

The new research points to the distinct effects that a single disease-causing gene variation can have across different regions of the brain.

The off-the-shelf treatment also had an impact on preventing or delaying cancer recurrence in high-risk patients.

Air samples collected in March and April 2025 showed traces of metals.

The research with local collaborators is the first to identify how to reliably grow ebony trees from seeds.

The sanctuaries protect fish that prey on other animals that eat kelp, helping it bounce back more quickly after a heat wave.

Mitochondria use folate in such quantities that invading Toxoplasma gondii grows more slowly. 

An email to renowned autism investigator Dr. Daniel Geschwind is leading to new science.

The new system could help enhance nationwide wildfire preparedness by combining satellite imagery with artificial intelligence.

The study found pembrolizumab shrank or eliminated tumors in nearly 90% of participants with desmoplastic melanoma that cannot be surgically removed.

UCLA neurobiologists have discovered that threadworms stop trying to penetrate human skin if a dopamine-sensing pathway is blocked.

The team will now seek FDA approval to open a clinical trial for the CAR-NKT cell therapy.

The clinical trial demonstrates that combining genetically engineered T cells and stem cells can produce cancer-fighting immune cells in humans.

The process could provide a versatile material platform for more powerful, compact and energy-efficient spintronic devices.

The locus coeruleus works like a “reset” button that separates the memory of one meaningful event from the next.

Researchers are working to launch a first-in-human clinical trial to test the approach.

The study was conducted across Los Angeles County.

The groundbreaking work is a scientific first.